Illness	Number of cases
Depressive episode - Major depressive disorder single episode moderate (F32.1)	147
Borderline personality disorder (F60.31)	99
Hyperkinetic disorders - Attention-deficit hyperactivity disorder predominantly hyperactive type (F90.1)	50
Reaction to severe stress and adjustment disorders - Acute stress reaction (F43.0)	34
Mental and behavioural disorders due to use of cannabinoids (F12.2)	32
Eating disorders - Anorexia nervosa unspecified (F50.00)	27
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances (F19.1)	19
Hyperkinetic disorders - Attention-deficit hyperactivity disorder predominantly inattentive type (F90.0)	15
Mental and behavioural disorders due to use of opioids (F11.2)	12
Eating disorders (F50.1)	11

Top 10 treatments

Treatment	Number
(1-931.0)	5.513
(9-693.02)	1.107
(9-696.40)	796
Intensive psychiatric-psychosomatic treatment for mental and psychosomatic disorders and behavioral disorders in children and adolescents (9-672)	613
(9-693.10)	428
(9-696.32)	382
(9-696.10)	374
(9-696.11)	352
(9-693.00)	313
(9-696.35)	302

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 3000

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ05
CQ25
CQ27

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
262	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
153	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
121	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Doctoral supervision
Lectureships / teaching posts at universities of applied sciences
Lectureships / teaching posts at colleges and universities
Editors of scientific journals/textbooks
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre Phase I/II studies	nur Phase-II-Studien
Participation in multi-centre phase III/IV studies

Training

No.	Training in other healing professions	Comment
HB03	Physical therapist / physiotherapist (m/f)	seit April 2022
HB05	Medical technical radiology assistant (MTRA) (m/f)	seit April 2021, seit 2023 neue Bundesgesetzgebung in Umsetzung
HB07	Surgical technical assistant (m/f)	ab 2022, neue Bundesgesetzgebung umgesetzt
HB09	Speech therapist (m/f)	seit Oktober 2022
HB10	Midwife (m/f)	seit Oktober 2021, Studium mit der Universität der Charité Berlin
HB12	Medical technical laboratory assistant (MTLA) (m/f)	seit Februar 2023, neue Bundesgesetzgebung umgesetzt
HB15	Anaesthesia technical assistant (m/f)	ab 2022, Bundesgesetzgebung umgesetzt
HB16	Dietician (m/f)	seit Oktober 2021
HB19	Nursing professionals	seit 2020, Pflegefachassistenz seit November 2022, Umsetzung der neuen Ausbildung nach Landesgesetzgebung
HB20	Nursing professional B. Sc.	Kooperationspartner für die ASH